RGLS

Regulus Therapeutics
RGLS

Overview Fund Activity
Delisted

RGLS was delisted on the 24th of June, 2025.

Back to rankings

25 hedge funds and large institutions have $15M invested in Regulus Therapeutics in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 12 increasing their positions, 1 reducing their positions, and 2 closing their positions.

Holders
25
Holders Change
-1
Holders Change %
-3.85%
% of All Funds
0.39%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
1
Increased
12
Reduced
1
Closed
2
Calls
$580K
Puts
–
Net Calls
+$580K
Net Calls Change
+$251K

Top Buyers

1
Federated Hermes
1
Federated Hermes
Pennsylvania
$5.7M
2
DCM
2
DAFNA Capital Management
California
$1.63M
3
NMC
3
NEA Management Company
Maryland
$2.86M
4
PCM
4
Prelude Capital Management
New York
$59.8K
5
Geode Capital Management
5
Geode Capital Management
Massachusetts
$166K

Top Sellers

1
Jane Street
1
Jane Street
New York
$0
2
TRCT
2
Tower Research Capital (TRC)
New York
$11.5K
3
Group One Trading
3
Group One Trading
Illinois
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Simplex Trading
26
Simplex Trading
Illinois
– – – –
Acadian Asset Management
27
Acadian Asset Management
Massachusetts
$0 466 – –
Susquehanna International Group
28
Susquehanna International Group
Pennsylvania
– – – –
Royal Bank of Canada
29
Royal Bank of Canada
Ontario, Canada
$0 206 +8 +4%
Barclays
30
Barclays
United Kingdom
$0 225 +220 +4,400%
1
2